CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?Zacks Investment Research • 07/17/24
Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market TodayZacks Investment Research • 07/10/24
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued.The Motley Fool • 06/27/24
Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?Zacks Investment Research • 06/24/24
CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call TranscriptSeeking Alpha • 06/11/24
Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)Seeking Alpha • 06/10/24
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?Zacks Investment Research • 06/07/24